Oral complications in a paediatric graft versus host disease (GVHD) clinic: A retrospective study

被引:1
|
作者
Emperumal, Chitra Priya [1 ,5 ]
Weller, Brett [2 ]
Okane, Sara [3 ]
Joseph, Renita [3 ]
Kharbanda, Sandhya [3 ]
Ling, Zhan [1 ]
Villa, Alessandro [1 ,4 ]
机构
[1] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Dent, San Francisco, CA USA
[3] Univ Calif San Francisco, Paediat Bone Marrow Transplant Program, San Francisco, CA USA
[4] Florida Int Univ, Miami Canc Inst, Herbert Wertheim Coll Med, Dept Translat Med,Baptist Hlth South Florida, Miami, FL USA
[5] Univ Calif San Francisco, Dept Orofacial Sci, 513 Parnassus Ave, s722, San Francisco, CA 94143 USA
关键词
allogeneic bone marrow transplants; oral cGHVD; oral manifestations; paediatric population; CONSENSUS DEVELOPMENT PROJECT; HEMATOPOIETIC-CELL TRANSPLANTATION; MANAGEMENT; CRITERIA; TRIALS; HEALTH; XEROSTOMIA; DIAGNOSIS; SURVIVORS; CHILDREN;
D O I
10.1111/odi.14535
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: The aim of this study was to investigate the oral health status among allogeneic transplant recipients who were seen in a multidisciplinary graft-versus-host disease paediatric clinic at the University of California, San Francisco (UCSF).Methods: This was a retrospective cohort study of patients who underwent allogeneic transplants and were seen in the graft-versus-host disease paediatric clinic between January 2010 and September 2021. Demographic, medical and oral health data were recorded and analysed using descriptive statistics.Results: A total of 25 patients were seen in the paediatric graft-versus-host disease clinic (68% males) with a median age of 12 years at the time of transplant were included. Among them, 12 patients (48%) were diagnosed with oral chronic GVHD, 11 (44%) with dry mouth, four (16%) with oral pseudomembranous candidiasis, one (4%) with recrudescent Herpes Simplex Virus (HSV) infection and one (4%) with mammalian target of rapamycin-inhibitor stomatitis and were managed by the oral medicine team, accordingly with medications, such as topical steroids (44%) and anti-fungal (20%).Conclusions: HSCT recipients may present with a variety of oral complications. Patients may benefit by a multi-disciplinary approach including a dental specialist as part of the cancer care team.
引用
收藏
页码:1084 / 1090
页数:7
相关论文
共 50 条
  • [41] Ruxolitinib: a game changer in paediatric chronic graft-versus-host disease management?
    Sisinni, Luisa
    LANCET HAEMATOLOGY, 2024, 11 (08): : e553 - e555
  • [42] Clinical Benefit of Response in Chronic Graft-versus-Host Disease
    Inamoto, Yoshihiro
    Martin, Paul J.
    Chai, Xiaoyu
    Jagasia, Madan
    Palmer, Jeanne
    Pidala, Joseph
    Cutler, Corey
    Pavletic, Steven Z.
    Arora, Mukta
    Jacobsohn, David
    Carpenter, Paul A.
    Flowers, Mary E. D.
    Khera, Nandita
    Vogelsang, Georgia B.
    Weisdorf, Daniel
    Storer, Barry E.
    Lee, Stephanie J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (10) : 1517 - 1524
  • [43] Biomarkers in chronic graft-versus-host disease: quo vadis?
    Wolff, D.
    Greinix, H.
    Lee, S. J.
    Gooley, T.
    Paczesny, S.
    Pavletic, S.
    Hakim, F.
    Malard, F.
    Jagasia, M.
    Lawitschka, A.
    Hansen, J. A.
    Pulanic, D.
    Holler, E.
    Dickinson, A.
    Weissinger, E.
    Edinger, M.
    Sarantopoulos, S.
    Schultz, K. R.
    BONE MARROW TRANSPLANTATION, 2018, 53 (07) : 832 - 837
  • [44] EXTRACORPOREAL PHOTOPHERESIS IN THE TREATMENT OF CHRONIC GRAFT-VERSUS-HOST- DISEASE
    Vasilyeva, V. A.
    Kuzmina, L. A.
    Drokov, M. Yu
    Dovydenko, M., V
    Koroleva, O. M.
    Dubnyak, D. S.
    Dmitrova, A. A.
    Nikiforova, N. M.
    Starikova, O. S.
    Komelskikh, D., V
    Sherbakova, A. A.
    Gaponova, T., V
    Parovichnikova, E. N.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (02): : 202 - 215
  • [45] Single-Center Retrospective Study on Meibomian Gland Loss in Patients With Ocular Chronic Graft-Versus-Host Disease
    Que, Lijuan
    Zhang, Xiaofeng
    Li, Mengmeng
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2018, 44 : S169 - S175
  • [46] Gene expression profile of chronic oral graft-versus-host disease
    Rocha Pinto, Giselle
    Sarmento, Viviane Almeida
    De Carvalho-Filho, Paulo Cirino
    Fortuna, Vitor Antonio
    Costa, Ryan dos Santos
    Conceicao, Rogerio Reis
    Trindade, Soraya Castro
    PLOS ONE, 2022, 17 (04):
  • [47] Oral Chronic Graft-versus-Host Disease and Oral Health after Allogeneic Hematopoietic Cell Transplantation - What the Care Team Needs to Know
    Laheij, Alexa M. G. A.
    Fregnani, Eduardo Rodrigues
    de Macedo, Leandro Dorigan
    Treister, Nathaniel S.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (09): : S548 - S558
  • [48] Ocular Involvement in Graft-versus-Host Disease
    Tappeiner, Christoph
    Heiligenhaus, Arnd
    Dietrich-Ntoukas, Tina
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2024, 241 (05) : 619 - 624
  • [49] Updates in chronic graft-versus-host disease
    Hamilton, Betty K.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 648 - 654
  • [50] Belumosudil for chronic graft-versus-host disease
    Taylor, Breanna
    Cohen, Jaimie
    Tejeda, Jennifer
    Wang, Trent Peng
    DRUGS OF TODAY, 2022, 58 (05) : 203 - 212